KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Gross Margin (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Gross Margin data on record, last reported at 60.35% in Q4 2025.

  • For Q4 2025, Gross Margin rose 55.0% year-over-year to 60.35%; the TTM value through Dec 2025 reached 61.8%, up 76.0%, while the annual FY2025 figure was 61.8%, 76.0% up from the prior year.
  • Gross Margin reached 60.35% in Q4 2025 per IDXX's latest filing, down from 61.83% in the prior quarter.
  • Across five years, Gross Margin topped out at 62.62% in Q2 2025 and bottomed at 56.97% in Q4 2021.
  • Average Gross Margin over 5 years is 60.19%, with a median of 60.26% recorded in 2023.
  • Peak YoY movement for Gross Margin: skyrocketed 307698bps in 2021, then crashed -91bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 56.97% in 2021, then rose by 3bps to 58.53% in 2022, then fell by 0bps to 58.36% in 2023, then rose by 2bps to 59.8% in 2024, then grew by 1bps to 60.35% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 60.35% in Q4 2025, 61.83% in Q3 2025, and 62.62% in Q2 2025.